HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senators Push Park Doctrine Prosecution For Spiked Supplement ‘Criminal Endeavors’

This article was originally published in The Tan Sheet

Executive Summary

Key industry allies say they are “deeply concerned” about “blatant criminal activity” in products marketed as supplements but containing anabolic steroids or other drugs. “Bring a few of these actions and you scare people into the idea that … you could actually go to jail,” says attorney Frederick Stearns.

You may also be interested in...



FDA Posts Criteria For Targeting Executives As Responsible Officers

FDA publishes criteria for filing criminal misdemeanor charges against executives from firms that break food and drug laws almost a year after the agency signaled its intent to pursue such cases.

Misdemeanor Charges Drive FDA's Park Doctrine Enforcement

FDA will push harder for federal prosecutors to take misdemeanor cases as the agency ramps up use of the Park Doctrine and strict liability statutes to prosecute corporate executives and others

US FDA ‘Punt’ On Hemp Rulemaking Frustrates, Confuses Supplement Industry

Industry trade groups say FDA decision against starting rulemaking for lawful use of hemp ingredients is not only overdue but failed to clear the air for businesses making or using the ingredients.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123844

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel